Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Authors: Trong Toan Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, Nan-Chang Chiu, Po-Yen Chen, Thi Tuong Vy Le, Dang Ngan Le, An Han Duong, Van Luan Nguyen, Thi Nguyet Huynh, Huu Khanh Truong, Trong Lan Phan, Thi Thanh Thao Nguyen, Shin-Ru Shih, Chung‑Guei Huang, Yi-Jen Weng, Erh-Fang Hsieh, Stanley Chang, Charles Chen, I-Chen Tai, Li-Min Huang
Institutions: Institut Pasteur in Ho Chi Minh City, Chang Gung University, Chang Gung Children's Hospital, Mackay Memorial Hospital, Mackay Medical University, Taichung Veterans General Hospital, Dong Thap Hospital, Children's Hospital 1, Medigen Vaccine Biologics Corporation (Taiwan), Temple University, National Taiwan University, National Taiwan University Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4223418136